Medical Ikkou Group Co Ltd operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medical Ikkou Group Co Ltd with three other
companies in this sector in JAPAN :
Sapporo Clinical Laboratory Inc.
sales of 17.66 billion Japanese Yen [US$166.70 million]
of which 62%
was Dispensing Pharmacy Business),
(16.69 billion Japanese Yen [US$157.52 million]
of which 56%
was Pharmaceutical segment), and
Pharmarise Holdings Corp
(51.03 billion Japanese Yen [US$481.72 million]
Medical Ikkou Group Co Ltd reported sales of ¥32.04 billion (US$302.48 million)
February of 2020.
increase of 2.6%
versus 2019, when the company's sales were ¥31.22 billion.
Sales at Medical Ikkou Group Co Ltd have increased during each of the previous five years
(and since 2015, sales have increased a total of 21%).
Sales of Healthcare saw an increase
4.4% in 2020, from
¥6.09 billion to ¥6.36 billion.
Not all segments of Medical Ikkou Group Co Ltd experienced an increase in sales in 2020:
sales of Real Estate fell 2.0% to ¥125.42 million.
(However, this segment's sales were only a very small portion of the company's overall sales).